Publications
By Year
Now showing items 4341-4360 of 5385 records
Augmented endothelial-specific L-arginine transport blunts the contribution of the sympathetic nervous system to obesity induced hypertension in mice
Rajapakse, NW; Karim, F; Head, GA; Evans, RG; Kaye, DM
PLOS ONE - 01 Jan 2015
Augmenting endothelial specific transport of the nitric oxide precursor L-arginine via cationic amino acid transporter-1 (CAT1) can prevent obesity related hypertension. We tested the hypotheses that CAT1 overexpression prevents obesity-induced hypertension by buffering the influence of the sympathetic nervous system (SNS) on the maintenance of arterial pressure and by buffering pressor respons...
Is there an association between sleeping patterns and other environmental factors with obesity and blood pressure in an Urban African population?
Carrington, MJ; Pretorius, S; Crowther, NJ; Sliwa, K; Lamont, K; Stewart, S
PLOS ONE - 01 Jan 2015
Beyond changing dietary patterns, there is a paucity of data to fully explain the high prevalence of obesity and hypertension in urban African populations. The aim of this study was to determine whether other environmental factors (including sleep duration, smoking and physical activity) are related to body anthropometry and blood pressure (BP). Data were collected on 1311 subjects, attending t...
Circulating lipids are associated with alcoholic liver cirrhosis and represent potential biomarkers for risk assessment
Mundra, PA; Rahman, K; Whitfield, JB; Seth, D; Duly, AM; Meikle, PJ; Wong, G; Haber, PS; Huynh, K; Barlow, CK
PLOS ONE - 01 Jan 2015
Liver disease is the greatest cause of death related to alcohol and a major public health problem. While excessive alcohol intake results in hepatosteatosis in most individuals, this can progress in some to more severe forms of liver disease including fibrosis and cirrhosis. An ongoing challenge in the management of alcoholic liver disease is the identification of liver injury early in the dise...
Relationship between inflammatory cytokines and indices of cardiac dysfunction following intense endurance exercise
Heidbuchel, H; La Gerche, A; Prior, DL; Inder, WJ; Brosnan, MJ; Roberts, TJ
PLOS ONE - 01 Jan 2015
OBJECTIVES: Pro-inflammatory cytokines have been noted to increase following exercise but their relationship to exercise-induced cardiac dysfunction has not previously been investigated. We sought to evaluate whether exercise-induced cardiac dysfunction was associated with increases in cytokines, particularly the pro-inflammatory cytokines IL-1β, IL-12p70 and TNFα, which have been most impli...
Identification and expression analysis of the barley (Hordeum vulgare L.) aquaporin gene family
Ziemann, M; Bhave, M; Hove, RM
PLOS ONE - 01 Jan 2015
Aquaporins (AQPs) are major intrinsic proteins (MIPs) that mediate bidirectional flux of water and other substrates across cell membranes, and play critical roles in plant-water relations, dehydration stress responses and crop productivity. However, limited data are available as yet on the contributions of these proteins to the physiology of the major crop barley (Hordeum vulgare). The present ...
The PKD inhibitor CID755673 enhances cardiac function in diabetic db/db mice
Connor, T; Elkamie, M; Venardos, K; McGee, SL; De Jong, KA
PLOS ONE - 01 Jan 2015
The development of diabetic cardiomyopathy is a key contributor to heart failure and mortality in obesity and type 2 diabetes (T2D). Current therapeutic interventions for T2D have limited impact on the development of diabetic cardiomyopathy. Clearly, new therapies are urgently needed. A potential therapeutic target is protein kinase D (PKD), which is activated by metabolic insults and implicate...
Accelerometer-derived sedentary and physical activity time in overweight/obese adults with type 2 diabetes: cross-sectional associations with cardiometabolic biomarkers
Winkler, EA; Reeves, MM; Brakenridge, CL; Healy, GN; Eakin, EG
PLOS ONE - 01 Jan 2015
OBJECTIVE: To examine the associations of sedentary time and physical activity with biomarkers of cardiometabolic health, including the potential collective impact of shifting mean time use from less- to more-active behaviours (cross-sectionally, using isotemporal substitution), in adults with type 2 diabetes. METHODS: Participants with overweight/obese body mass index (BMI; ≥25 kg/m2) (...
Short-term treatment with diminazene aceturate ameliorates the reduction in kidney ACE2 activity in rats with subtotal nephrectomy
Tikellis, C; Velkoska, E; Pickering, RJ; Griggs, K; Burrell, LM; Patel, SK
PLOS ONE - 01 Jan 2015
Angiotensin converting enzyme (ACE) 2 is an important modulator of the renin angiotensin system (RAS) through its role to degrade angiotensin (Ang) II. Depletion of kidney ACE2 occurs following kidney injury due to renal mass reduction and may contribute to progressive kidney disease. This study assessed the effect of diminazine aceturate (DIZE), which has been described as an ACE2 activator, o...
The dual-specificity phosphatase 2 (DUSP2) does not regulate obesity-associated inflammation or insulin resistance in mice
Estevez, E; Gerondakis, S; Kraakman, MJ; Kammoun, HL; Febbraio, MA; Langley, KG; Banerjee, A; Lancaster, GI; Grumont, RJ
PLOS ONE - 01 Jan 2014
Alterations in the immune cell profile and the induction of inflammation within adipose tissue are a hallmark of obesity in mice and humans. Dual-specificity phosphatase 2 (DUSP2) is widely expressed within the immune system and plays a key role promoting immune and inflammatory responses dependent on mitogen-activated protein kinase (MAPK) activity. We hypothesised that the absence of DUSP2 wo...
Global systematic review of the cost-effectiveness of indigenous health interventions
Eades, S; Jan, S; Irving, M; Muhunthan, J; Angell, BJ
PLOS ONE - 01 Jan 2014
BACKGROUND: Indigenous populations around the world have consistently been shown to bear a greater burden of disease, death and disability than their non-Indigenous counterparts. Despite this, little is known about what constitutes cost-effective interventions in these groups. The objective of this paper was to assess the global cost-effectiveness literature in Indigenous health to identify ...
Abnormal mitochondrial L-arginine transport contributes to the pathogenesis of heart failure and rexoygenation injury
Williams, D; Venardos, KM; Lam, NT; McGee, SL; Horlock, D; Gregorovic, P; Kaye, DM; Joshi, M; Byrne, M
PLOS ONE - 01 Jan 2014
BACKGROUND: Impaired mitochondrial function is fundamental feature of heart failure (HF) and myocardial ischemia. In addition to the effects of heightened oxidative stress, altered nitric oxide (NO) metabolism, generated by a mitochondrial NO synthase, has also been proposed to impact upon mitochondrial function. However, the mechanism responsible for arginine transport into mitochondria and t...
In vitro palmitate treatment of myotubes from postmenopausal women leads to ceramide accumulation, inflammation and affected insulin signaling
Henstridge, DC; Langley, KG; Scheele, C; Lindegaard, B; Pedersen, AT; Pedersen, BK; Abildgaard, J
PLOS ONE - 01 Jan 2014
Menopause is associated with an increased incidence of insulin resistance and metabolic diseases. In a chronic palmitate treatment model, we investigated the role of skeletal muscle fatty acid exposure in relation to the metabolic deterioration observed with menopause. Human skeletal muscle satellite cells were isolated from premenopausal (n = 6) and postmenopausal (n = 5) women. In an in vitro...
Point-of-care testing for chlamydia and gonorrhoea: implications for clinical practice
Ward, J; Shephard, M; Hengel, B; Badman, SG; Natoli, L; Maher, L; Tangey, A; Guy, RJ
PLOS ONE - 01 Jan 2014
OBJECTIVES: Point-of-care (POC) testing for chlamydia (CT) and gonorrhoea (NG) offers a new approach to the diagnosis and management of these sexually transmitted infections (STIs) in remote Australian communities and other similar settings. Diagnosis of STIs in remote communities is typically symptom driven, and for those who are asymptomatic, treatment is generally delayed until specimens ca...
Raised soluble P-selectin moderately accelerates atherosclerotic plaque progression
Irvine, JC; Woollard, KJ; Bobik, A; Jefferis, AM; Lumsden, NG; Chin-Dusting, JP; Harris, E; Fang, L; Andrews, KL; Aprico, A; Kanellakis, P
PLOS ONE - 01 Jan 2014
Soluble P-selectin (sP-selectin), a biomarker of inflammatory related pathologies including cardiovascular and peripheral vascular diseases, also has pro-atherosclerotic effects including the ability to increase leukocyte recruitment and modulate thrombotic responses in vivo. The current study explores its role in progressing atherosclerotic plaque disease. Apoe-/- mice placed on a high fat die...
Transcriptome-based analysis of kidney gene expression changes associated with diabetes in OVE26 mice, in the presence and absence of losartan treatment
McClelland, A; Kantharidis, P; Cohen, HT; Cohen, DM; Fu, Y; Komers, R; Xu, B; Mittal, A
PLOS ONE - 01 Jan 2014
Diabetes is among the most common causes of end-stage renal disease, although its pathophysiology is incompletely understood. We performed next-generation sequencing-based transcriptome analysis of renal gene expression changes in the OVE26 murine model of diabetes (age 15 weeks), relative to non-diabetic control, in the presence and absence of short-term (seven-day) treatment with the angioten...
Plasma lipidomic profiling of treated HIV-positive individuals and the implications for cardiovascular risk prediction
Weir, JM; Hoy, JF; Trevillyan, JM; Cinel, M; Meikle, PJ; Fatou, B; Wong, G
PLOS ONE - 01 Jan 2014
BACKGROUND: The increased risk of coronary artery disease in human immunodeficiency virus (HIV) positive patients is collectively contributed to by the human immunodeficiency virus and antiretroviral-associated dyslipidaemia. In this study, we investigate the characterisation of the plasma lipid profiles of treated HIV patients and the relationship of 316 plasma lipid species across multiple l...
Hospitalisations for pelvic inflammatory disease temporally related to a diagnosis of Chlamydia or gonorrhoea: a retrospective cohort study
Ward, J; Kaldor, JM; Roberts, CL; Wand, H; Guy, R; Preen, D; Donovan, B; Stewart, L; Pearson, S; Hocking, JS; Mak, DB; Liu, B; Jorm, L; Reekie, J
PLOS ONE - 01 Jan 2014
OBJECTIVES: The presence and severity of pelvic inflammatory disease (PID) symptoms are thought to vary by microbiological etiology but there is limited empirical evidence. We sought to estimate and compare the rates of hospitalisation for PID temporally related to diagnoses of gonorrhoea and chlamydia. METHODS: All women, aged 15-45 years in the Australian state of New South Wales (NSW), wi...
Direct evidences for sympathetic hyperactivity and baroreflex impairment in Tako Tsubo cardiopathy
Esler, M; Lambert, G; Guiraud, T; Lairez, O; Labrunee, M; Delmas, C; Senard, JM; Pathak, A; Vaccaro, A; Galinier, M; Despas, F; Lambert, E
PLOS ONE - 01 Jan 2014
BACKGROUND: The exact pathophysiology of Tako-Tsubo cardiomyopathy (TTC) remains unknown but a role for sympathetic hyperactivity has been suggested. Up to now, no direct evidence of sympathetic nerve hyperactivity has been established nor involvement of sympathetic baroreflex identified. The aim of our study was to determine, by direct sympathetic nerve activity (SNS) recording if sympathetic...
Predictors of mean arterial pressure morning rate of rise and power function in subjects undergoing ambulatory blood pressure recording
Carrington, MJ; Martin, CA; Andrianopoulos, N; Lukoshkova, EV; Head, GA; Davern, PJ; Reid, CM; McGrath, BP; Jennings, GL
PLOS ONE - 01 Jan 2014
BACKGROUND: We determined clinical predictors of the rate of rise (RoR) in blood pressure in the morning as well as a novel measure of the power of the BP surge (BP(power)) derived from ambulatory blood pressure recordings. METHODS: BP(power) and RoR were calculated from 409 ambulatory blood pressure (ABP) recordings from subjects attending a cardiovascular risk clinic. Anthropometric data, ...
Rapid development of non-alcoholic steatohepatitis in Psammomys obesus (Israeli sand rat)
Abreu, LL; Spolding, B; El-Osta, A; Wittmer, C; Kaspi, A; Sinclair, A; Gibert, Y; Morrison, S; Lee, S; Connor, T; Trevaskis, JL; Ziemann, M; Roth, JD; Walder, K; Cooper, A; Standish, R; Kaur, G
PLOS ONE - 01 Jan 2014
BACKGROUND AND AIMS: A major impediment to establishing new treatments for non-alcoholic steatohepatitis is the lack of suitable animal models that accurately mimic the biochemical and metabolic characteristics of the disease. The aim of this study was to explore a unique polygenic animal model of metabolic disease as a model of non-alcoholic steatohepatitis by determining the effects of 2% di...
Show more...